These compounds include paclitaxel, flavones, vernodalin, epigallocatechin-3- gallate (EGCG), eugenol, and quercetin (Belguise et al., 2007; Lin et al., 2015), all of which exert their inhibitory effects on breast cancer through their impact on FOXO3a signal transduction. The gene discussed is FOXO3; the disease is breast carcinoma.